论文部分内容阅读
目的:比较分析参芪降糖颗粒治疗2型糖尿病患者的临床效果,并进行评价。方法:选取我院2009年1月至2011年12月内收治的150例2型糖尿病患者,将其分成对照组与实验组进行试验。实验组患者在常规治疗的基础上服用参芪降糖颗粒;对照组患者仅进行常规降糖治疗。一段时间之后,检测分析两组患者治疗前后的临床症状、血糖、血脂、血胆固醇等指标的变化情况。结果:治疗后,实验组和对照组患者的空腹血糖等指标均有不同程度的改善,其中,实验组治疗前后的血糖浓度、胆固醇浓度变化较大,具有显著差异性。结论:参芪降糖颗粒能够明显降低2型糖尿病患者的血糖、血脂等临床指标,具有较好的临床疗效,值得临床推广应用。
Objective: To compare and analyze the clinical effect of Shenqi Jiangtang Granule in treating type 2 diabetic patients. Methods: 150 type 2 diabetic patients admitted to our hospital from January 2009 to December 2011 were selected and divided into control group and experimental group. Patients in the experimental group took Shenqi Jiangtang Granule on the basis of routine treatment. Patients in the control group only received routine hypoglycemic treatment. After a period of time, the two groups of patients before and after testing the clinical symptoms, blood glucose, blood lipids, blood cholesterol and other indicators of change. Results: After treatment, the fasting blood glucose and other indexes in the experimental group and the control group all improved to some extent. Among them, the blood glucose concentration and the concentration of cholesterol in the experimental group changed greatly before and after treatment, with significant differences. Conclusion: Shenqijiangtang granules can significantly reduce the blood glucose, blood lipid and other clinical indicators in patients with type 2 diabetes mellitus, has a good clinical efficacy, worthy of clinical promotion and application.